EMAIL THIS PAGE TO A FRIEND

Molecular cancer therapeutics

Loss of Tuberous Sclerosis Complex 2 (TSC2) Is Frequent in Hepatocellular Carcinoma and Predicts Response to mTORC1 Inhibitor Everolimus.


PMID 25724664

Abstract

Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide and hyperactivation of mTOR signaling plays a pivotal role in HCC tumorigenesis. Tuberous sclerosis complex (TSC), a heterodimer of TSC1 and TSC2, functions as a negative regulator of mTOR signaling. In the current study, we discovered that TSC2 loss-of-function is common in HCC. TSC2 loss was found in 4 of 8 HCC cell lines and 8 of 28 (28.6%) patient-derived HCC xenografts. TSC2 mutations and deletions are likely to be the underlying cause of TSC2 loss in HCC cell lines, xenografts, and primary tumors for most cases. We further demonstrated that TSC2-null HCC cell lines and xenografts had elevated mTOR signaling and, more importantly, were significantly more sensitive to RAD001/everolimus, an mTORC1 inhibitor. These preclinical findings led to the analysis of TSC2 status in HCC samples collected in the EVOLVE-1 clinical trial of everolimus using an optimized immunohistochemistry assay and identified 15 of 139 (10.8%) samples with low to undetectable levels of TSC2. Although the sample size is too small for formal statistical analysis, TSC2-null/low tumor patients who received everolimus tended to have longer overall survival than those who received placebo. Finally, we performed an epidemiology survey of more than 239 Asian HCC tumors and found the frequency of TSC2 loss to be approximately 20% in Asian HBV(+) HCC. Taken together, our data strongly argue that TSC2 loss is a predictive biomarker for the response to everolimus in HCC patients.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

H2538
Anti-Hamartin antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
PRS3503
Anti-TSC1 (ab1) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
PRS3505
Anti-TSC1 (ab2) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
PRS3507
Anti-TSC2 (ab1) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
PRS3509
Anti-TSC2 (ab2) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
HPA030409
Anti-TSC2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4503037
Anti-TSC2 antibody produced in rabbit, affinity isolated antibody
SAB4503038
Anti-TSC2, C-Terminal antibody produced in rabbit, affinity isolated antibody
T9574
Anti-Tuberin (IA-22) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
T5075 Anti-Tuberin (VV-18) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB4503039
Anti-Tuberin antibody produced in rabbit, affinity isolated antibody
CKOZFN1074 CompoZr® Knockout ZFN Kit, human TSC2 (NM_000548)
SAB1402949
Monoclonal Anti-TSC2 antibody produced in mouse, clone 1C1, purified immunoglobulin, buffered aqueous solution